Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Osteochondritis

ClinicalTrials.gov lists 32 trials for Osteochondritis or a narrower condition beneath it. Zimmer Orthobiologics, Inc. has the most among industry and government lead sponsors, with 3.

MeSH D010007 Musculoskeletal Diseases C05 C17
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 3 Phase 3 4 Phase 4 Phase 4 1 Not applicable Not applicable 13 Observational Observational 12 Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 3 Phase 3 4 Phase 4 Phase 4 1 Not applicable Not applicable 13 Observational Observational 12

Trials per phase

5 of the 32 trials are tagged with Osteochondritis itself; the rest are tagged with a narrower condition beneath it.

Get the Osteochondritis report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Osteochondritis trials start? (15)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 3
  • Not applicable
  • Observational

Top of scale: 6

2003: 1 trials (Phase 3 1) 2009: 1 trials (Not applicable 1) 2010: 3 trials (Observational 1, Not applicable 1, Phase 1 1) 2011: 6 trials (Observational 3, Not applicable 3) 2012: 2 trials (Phase 3 1, Phase 1/2 1) 2013: 2 trials (Not applicable 2) 2014: 2 trials (Observational 1, Not applicable 1) 2015: 1 trials (Not applicable 1) 2016: 1 trials (Not applicable 1) 2017: 2 trials (Observational 1, Not applicable 1) 2018: 3 trials (Observational 2, Phase 3 1) 2019: 1 trials (Observational 1) 2022: 1 trials (Observational 1) 2024: 1 trials (Observational 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 4
2024 1
2022 1
2019 1
2018 3
2017 2
2016 1
2015 1
2014 2
2013 2

No forecast is made for this condition: it averages 1.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Osteochondritis trials in? (6)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 1/2 1
Phase 3 4
Phase 4 1
Not applicable 13
Observational 12

How many Osteochondritis trials are recruiting? (8)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Recruiting 8
Enrolling by invitation 1
Active, not recruiting 2
Completed 8

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Osteochondritis trials? (5)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Zimmer Orthobiologics, Inc. 3
Vericel Corporation 2
DePuy Mitek 1
Fin-Ceramica Faenza Spa 1
Geistlich Pharma AG 1

Which drugs are being tested for Osteochondritis? (1)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
MACI 1

Interventions as named in the registry (5)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
[PRP] platelet rich plasma 1
CS-ACI 1
MRI 1
autologous cultured chondrocytes on porcine collagen membrane 1
Bone Marrow Stimulation 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Osteochondritis? (27)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. The American journal of sports medicine 2012 Yes
Is radiographic evaluation necessary in children with a clinical diagnosis of calcaneal apophysitis (sever disease)? Journal of pediatric orthopedics 2011 Yes
Cartilage repair evolution in post-traumatic osteochondral lesions of the talus: from open field autologous chondrocyte to bone-marrow-derived cells transplantation. Injury 2010 Yes
Osgood Schlatter syndrome. Current opinion in pediatrics 2007 Yes
Osteochondral lesions of the talar dome associated with trauma. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association 2003 Yes

Sub-conditions in MeSH (1)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, and rare-disease identity.

Browse all condition evidence pages